11 July 2025
Kia ora, In this issue Insights from our Executive Director We are all acutely aware of how tough things are, but the biotech sector never ceases to amaze me. There … Continue reading "Medicinal cannabis summit timely given economic challenges"
Read More
10 July 2025
New Zealand has the research excellence, innovation mindset, and community strength to compete globally. Now is the time to: Let’s take inspiration from global leaders and shape a bold, connected, … Continue reading "Medicinal cannabis summit timely given economic challenges"
Read More
29 May 2025
Our new Executive Council has been focused on enhancing member value, ensuring you receive maximum benefit from your membership while we deliver what matters most to you.
Read More
18 March 2025
In this issue Insights from our Executive Director Reflecting on our journey from 2017—when NZBIO faced financial challenges and joined the NZTech Group—to today is truly remarkable. Four years of … Continue reading "Medicinal cannabis summit timely given economic challenges"
Read More
12 February 2025
In this issue Insights from our Executive Director As we kick off the year, BioTechNZ is already moving full speed ahead with exciting developments in the biotech sector. There is … Continue reading "Medicinal cannabis summit timely given economic challenges"
Read More
16 December 2024
It has been a landmark year for BioTechNZ and our members. Let's take a moment to reflect on the progress and achievements of 2024!
Read More
30 September 2024
Kia ora, In this issue Insights from our Executive Director The more I work in this role the more excited I am about the convergence of once-siloed technologies across multidisciplinary … Continue reading "Medicinal cannabis summit timely given economic challenges"
Read More
03 September 2024
In this issue Insights from our Executive Director During the last month there has been plenty of discussion in the media regarding gene technologies – should our companies and researchers … Continue reading "Medicinal cannabis summit timely given economic challenges"
Read More
02 September 2024
We can’t wait to reconnect at Aotearoa New Zealand’s 2025 Life Science Summit – Uniting biology and technology to unleash potential. 18-19 March, 2025 at Tākina Wellington Convention and Exhibition Centre. Click here … Continue reading "Medicinal cannabis summit timely given economic challenges"
Read More
21 June 2024
It has been another busy month for biotech. More than 35 Kiwis travelled to the BIO International Convention in San Diego.
Read More
06 March 2024
In this issue Insights from our Executive Director This year feels like it’s going to be a fast game, but a good game for the biotech sector! I am incredibly … Continue reading "Medicinal cannabis summit timely given economic challenges"
Read More
It’s only two months until New Zealand’s first medicinal cannabis summit, MedCan 2020, with organisers saying the economic potential of New Zealand’s most exciting sunrise industry is more important than ever before. MedCan Summit 2020 will take place on Monday 9 and Tuesday 10 N
September 7, 2020
Many friends and colleagues attended the Aroa Biosurgery (ASX:ARX) listing on the ASX, ceremony and celebration at the end of July. Aroa is a soft-tissue regeneration company, founded in 2008.“You all know biotechnology is an important part of New Zealand's future” Peter Hodgson, Rese
August 18, 2020
For those members who were unable to join us for the Annual Meeting on 21st July 2020, you can view the meeting presentation here.
July 22, 2020
The Precautionary Principle, there are many definitions, but the most common expression today claims that a practice, substance or technology must be banned or prohibited if it cannot be proven (with certainty) to be safe. Rather than trying to reduce exposure to risks or solve problems with innova
July 3, 2020
Congratulations to our Neonatal expert Professor Jane Harding as she is now one of the Dame Companions of the New Zealand Order of Merit (NZOM). Congratulations also to medical researcher Professor Robert Elliott who has been appointed Knight Companions of the NZOM. Well deserved recog
June 3, 2020
Auckland-based biotechnology company Pictor has received a double funding boost from government and partners for two crucial development projects to help combat COVID-19 and Mycoplasma bovis. Pictor has received a grant of $500,000 from the $25 million MBIE COVID-19 Innovation Acceleration Fund,
May 18, 2020
New Zealand biotech Avalia Immunotherapies has been awarded bridging funding of $100,000 from the Ministry of Business, Innovation and Employment’s COVID-19 Innovation Acceleration Fund to start work on securing a COVID-19 vaccine for New Zealand, until a national vaccine strategy is in place.
May 8, 2020
Currently, an estimated 2.6 billion people – one-third of the world’s population – are living under some kind of lockdown or quarantine. This is arguably the largest social and economic experiment ever conducted. There are lots of coronavirus memes on the internet, however,&
May 6, 2020
Some of New Zealand’s top scientists are urging the need for a national COVID-19 vaccine programme to ensure New Zealand is best placed to access an effective vaccine at the earliest opportunity. Malaghan Institute Director Professor Graham Le Gros and University of Otago’s Professor Miguel
April 15, 2020